Rankings
▼
Calendar
HRTX Q4 2023 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$162M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$34M
+14.0% YoY
Gross Profit
$24M
71.1% margin
Operating Income
-$10M
-29.9% margin
Net Income
-$11M
-31.3% margin
EPS (Diluted)
$-0.07
QoQ Revenue Growth
+8.9%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$223M
Total Liabilities
$256M
Stockholders' Equity
-$34M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$30M
+14.0%
Gross Profit
$24M
$17M
+39.9%
Operating Income
-$10M
-$20M
+49.8%
Net Income
-$11M
-$20M
+46.0%
Revenue Segments
C I N V A N T I
$48M
73%
Z Y N R E L E F
$10M
16%
S U S T O L
$7M
11%
← FY 2023
All Quarters
Q1 2024 →